Xiangyu Medical Co.,Ltd (688626.SS)
CNY 34.06
(-4.06%)
CNY 34.06
(-4.06%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 264.89 Million CNY | 80.13% |
| 2022 | 149.24 Million CNY | -35.01% |
| 2021 | 236.47 Million CNY | 0.72% |
| 2020 | 233.73 Million CNY | 49.54% |
| 2019 | 157.6 Million CNY | 52.09% |
| 2018 | 103.25 Million CNY | 22.82% |
| 2017 | 83.97 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 18.85 Million CNY | -38.49% |
| 2024 Q1 | 45.07 Million CNY | -16.73% |
| 2024 Q2 | 17.88 Million CNY | -42.9% |
| 2023 Q3 | 77.18 Million CNY | 6.22% |
| 2023 FY | - CNY | 80.13% |
| 2023 Q4 | 66.59 Million CNY | -13.72% |
| 2023 Q2 | 72.66 Million CNY | 59.99% |
| 2023 Q1 | 45.41 Million CNY | 17.78% |
| 2022 Q3 | 53.82 Million CNY | 52.36% |
| 2022 Q2 | 35.32 Million CNY | 203.44% |
| 2022 Q1 | 11.64 Million CNY | -87.95% |
| 2022 FY | - CNY | -35.01% |
| 2022 Q4 | 38.56 Million CNY | -28.35% |
| 2021 Q4 | 96.6 Million CNY | 204.66% |
| 2021 Q1 | 38.05 Million CNY | 142.23% |
| 2021 FY | - CNY | 0.72% |
| 2021 Q3 | 31.7 Million CNY | -48.35% |
| 2021 Q2 | 61.38 Million CNY | 61.29% |
| 2020 Q1 | 24.28 Million CNY | 116.6% |
| 2020 Q4 | -90.12 Million CNY | -140.13% |
| 2020 Q3 | 224.58 Million CNY | 241.05% |
| 2020 Q2 | 65.85 Million CNY | 171.19% |
| 2020 FY | - CNY | 49.54% |
| 2019 FY | - CNY | 52.09% |
| 2019 Q4 | -146.29 Million CNY | 0.0% |
| 2018 FY | - CNY | 22.82% |
| 2017 FY | - CNY | 0.0% |